Showing results (391-400 of 2,338) with videos related to

Sort By:
Pageof 234
Clinical Lung Cancer|March 17, 2020
Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based ChemotherapySusanne M Arnold, Kari Chansky, Maria Q Baggstrom, et al.
Clinical Lung Cancer|December 15, 2020
Predictive and Prognostic Potential of TP53 in Patients With Advanced Non-Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901)Xiang-Meng Li, Wen-Feng Li, Jun-Tao Lin, et al.
Clinical Lung Cancer|November 2, 2020
Ultra-central Thoracic Re-irradiation Using 10-fraction Stereotactic Body Radiotherapy for Recurrent Non-small-cell Lung Cancer Tumors: Preliminary Toxicity and Efficacy OutcomesSumit Sood, Rohit Ganju, Xinglei Shen, et al.
Clinical Lung Cancer|August 27, 2022
A Multi-Center Real-World Experience of IMpower150 in Oncogene Driven Tumors and CNS MetastasesMalinda Itchins, Hannah Ainsworth, Marliese Alexander, et al.
Clinical Lung Cancer|October 21, 2022
Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung CancerSabine Schmid, Sierra Cheng, Simren Chotai, et al.
Clinical Lung Cancer|March 19, 2021
RADIORYTHMIC: Phase III, Opened, Randomized Study of Postoperative Radiotherapy Versus Surveillance in Stage IIb/III of Masaoka Koga Thymoma after Complete Surgical ResectionC Basse, A Botticella, T J Molina, et al.
Clinical Lung Cancer|March 13, 2021
Improved Survival Outcomes in Medically Fit Patients With Early-Stage Non-Small-Cell Lung Cancer Undergoing Stereotactic Body RadiotherapyJason Liu, Caressa Hui, Colton Ladbury, et al.
Clinical Lung Cancer|February 23, 2021
Recent Advances in the Management of Typical and Atypical Lung CarcinoidsNatalie Prinzi, Roberta Elisa Rossi, Claudia Proto, et al.
Clinical Lung Cancer|November 22, 2021
A Multicenter, Randomized Phase III Study Comparing Platinum Combination Chemotherapy Plus Pembrolizumab With Platinum Combination Chemotherapy Plus Nivolumab and Ipilimumab for Treatment-Naive Advanced Non-Small Cell Lung Cancer Without Driver Gene Alterations: JCOG2007 (NIPPON Study)Yoshimasa Shiraishi, Taiki Hakozaki, Shogo Nomura, et al.
Clinical Lung Cancer|October 20, 2022
Incidence of Pneumonitis Among Limited Stage Small Cell Lung Cancer Patients Exposed to Concurrent Chemoradiation: A Systematic Literature Review and Meta-AnalysisYuting Kuang, Rajpal Singh, Arianna Nevo, et al.
Pageof 234